Hidradenitis Suppurativa Prospective Observational Registry and Biospecimen Repository

Description

Hidradenitis suppurativa (HS) is a common and debilitating skin disease that is poorly understood and understudied. As a result, little is known about disease prognosis and few effective treatments exist for this condition. This prospective observational cohort study aims to comprehensively characterize the clinical and biological features of HS. The results of this research will provide a basis for the development of an HS clinical classification system and identification of potential treatments for HS.

Conditions

Hidradenitis Suppurativa

Study Overview

Study Details

Study overview

Hidradenitis suppurativa (HS) is a common and debilitating skin disease that is poorly understood and understudied. As a result, little is known about disease prognosis and few effective treatments exist for this condition. This prospective observational cohort study aims to comprehensively characterize the clinical and biological features of HS. The results of this research will provide a basis for the development of an HS clinical classification system and identification of potential treatments for HS.

Hidradenitis Suppurativa Prospective Observational Registry and Biospecimen Repository

Hidradenitis Suppurativa Prospective Observational Registry and Biospecimen Repository

Condition
Hidradenitis Suppurativa
Intervention / Treatment

-

Contacts and Locations

San Francisco

University of California San Francisco, San Francisco, California, United States, 94115

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Male or female ≥ 10 years of age
  • 2. Diagnosis of HS by a dermatologist or practitioner experienced in making a diagnosis of HS
  • 3. Written informed consent (and assent when applicable) obtained from subject or subject's legal representative and ability for subject to comply with the requirements of the study.
  • 1. Inability to give informed consent or unavailability of a parent/guardian who is able and willing to give informed consent.

Ages Eligible for Study

10 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of California, San Francisco,

Haley B Naik, MD, MHSc, FAAD, PRINCIPAL_INVESTIGATOR, University of California, San Francisco

Study Record Dates

2030-01-01